|
OmniComm Systems Appoints EDC Veteran Dr. Wolfgang Summa to Executive Vice President,
Europe & Asia/Pacific
OMNICOMM CONTINUES ITS EXPANSION INTO EUROPE AND STRENGTHENS ITS SENIOR MANAGEMENT
TEAM
FT. LAUDERDALE, Fla., May 12 /PRNewswire-FirstCall/ -- OmniComm Systems, Inc. (OTC
Bulletin Board: OMCM.OB), a leader in integrated electronic data capture (EDC) solutions
for clinical trials, today announced that it has strengthened its European presence
and management team with the addition of Dr. Wolfgang Summa. As Executive Vice President,
Europe & Asia/Pacific based in OmniComm’s Bonn, Germany facility, Dr. Summa will
be focused on the expansion of our products and services throughout Europe and the
Asia Pacific area.
"OmniComm is well positioned to offer leading edge products and services to the
international community," said Cornelis F. Wit, CEO of OmniComm. "We have expanded
our client services in Europe to include help desk support in eight languages and
added clinical and professional services expertise, along with additional project
management, quality assurance, development and sales and marketing. Dr. Summa will
be a strong addition to an already seasoned team in Europe."
Dr. Summa comes to OmniComm most recently from invivodata, where he spent 2 years
as Vice President Europe & Asia Pacific, leading the European operational and business
development team and driving the expansion of patient diary solutions in the European
and Asian markets. Prior to invivodata, Dr. Summa held positions ranging from Vice
President Global Operations to Vice President Enterprise Consulting and Managing
Director Europe at DATATRAK International. Dr. Summa also serves as member of the
European Coordinating Committee of CDISC (Clinical Data Interchange Standards Consortium).
Dr. Summa has 14 years of experience in the pharmaceutical industry with a strong
focus on EDC and new technologies.
"I am excited about joining the OmniComm team," said Dr. Summa. "The unique combination
of product vision and outstanding customer service makes this company the ideal
partner for global customers. Working with an excellent team of experienced EDC
executives makes this a great place to work."
About OmniComm
OmniComm Systems, Inc. (www.OmniComm.com)
provides customer-driven Internet solutions to pharmaceutical, biotechnology, research
and medical device organizations that conduct life changing clinical trial research.
OmniComm's growing base of satisfied customers is a direct result of the company's
commitment to deliver products and services that ensure ease of use, faster study
build, ease of integration and better performance. OmniComm's client intuitive pricing
model allows companies that range from small, to mid-size to large scale institutions
to safely and efficiently capitalize on their clinical research investments. OmniComm
Systems, Inc. has corporate headquarters in Ft. Lauderdale, Florida with offices
in Bonn, Chicago, Germany, Tula, Russia, California, New York, North Carolina, Tennessee,
Massachusetts and Georgia.
Safe Harbor Disclaimer
Statements about OmniComm's future expectations, including without limitation, future
revenues and earnings, plans and objectives for the future operations, future agreements,
future economic performance, operations and all other statements in this press release
other than historical facts are "forward-looking statements" within the meaning
of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange
Act of 1934, and as that term is defined in the Private Securities Litigation Reform
Act of 1995. OmniComm intends that such forward-looking statements be subject to
the Safe Harbors created thereby. Since these statements involve risks and uncertainties,
including but not limited to economic competitive, governmental, contractual and
technological factors affecting OmniComm's operations, markets and profitability,
actual results could differ materially and adversely from the expected results.
CONTACT: Steve Johnson, OmniComm Systems, Inc., +1-954-473-1254
sjohnson@omnicomm.com
Back
|
